Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border.


Journal

Salud publica de Mexico
ISSN: 1606-7916
Titre abrégé: Salud Publica Mex
Pays: Mexico
ID NLM: 0404371

Informations de publication

Date de publication:
02 Jan 2023
Historique:
received: 20 06 2022
accepted: 13 10 2022
pmc-release: 02 01 2024
entrez: 7 2 2023
pubmed: 8 2 2023
medline: 10 2 2023
Statut: epublish

Résumé

To interrogate the circulating SARS-CoV-2 lin-eages and recombinant variants in persons living in migrant shelters and persons who inject drugs (PWID). We combined data from two studies with marginalized populations (migrants in shelters and persons who inject drugs) in Tijuana, Mexico. SARS-CoV-2 variants were identified on nasal swabs specimens and compared to publicly available genomes sampled in Mexico and California. All but 2 of the 10 lineages identified were predomi-nantly detected in North and Central America. Discrepan-cies between migrants and PWID can be explained by the temporal emergence and short time span of most of these lineages in the region. The results illustrate the temporo-spatial structure for SARS-CoV-2 lineage dispersal and the potential co-circulation of multiple lineages in high-risk populations with close social contacts. These conditions create the potential for recombination to take place in the California-Baja California border.

Identifiants

pubmed: 36750073
doi: 10.21149/13980
pmc: PMC10291843
mid: NIHMS1881622
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-18

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA049644
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA055491
Pays : United States

Références

Nature. 2021 Jul;595(7869):713-717
pubmed: 34192736
Am J Public Health. 2009 Aug;99(8):1491-5
pubmed: 19542040
PLoS One. 2008 Jul 30;3(7):e2690
pubmed: 18665250
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):369-76
pubmed: 18176320
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Int Migr. 2014 Aug 1;52(4):26-40
pubmed: 25346548
BMJ Glob Health. 2022 Mar;7(3):
pubmed: 35277428
PLoS Pathog. 2014 Feb 20;10(2):e1003932
pubmed: 24586153
Cell Host Microbe. 2022 Aug 10;30(8):1112-1123.e3
pubmed: 35853454
Microb Genom. 2016 Nov 30;2(11):e000093
pubmed: 28348833
J Migr Health. 2021;3:100041
pubmed: 33903857
EClinicalMedicine. 2021 Jul 01;37:100958
pubmed: 34258570
PLoS One. 2021 Nov 22;16(11):e0260286
pubmed: 34807963
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):817-823
pubmed: 32540735
Mol Psychiatry. 2021 Jan;26(1):30-39
pubmed: 32929211
Subst Use Misuse. 2018 Jul 29;53(9):1558-1570
pubmed: 29364762
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Wellcome Open Res. 2021 May 19;6:121
pubmed: 34095513
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
PLoS One. 2021 Mar 31;16(3):e0248336
pubmed: 33788848
BMC Public Health. 2020 Jun 30;20(1):1039
pubmed: 32605605
Harm Reduct J. 2021 Nov 24;18(1):118
pubmed: 34819070
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681

Auteurs

Antoine Chaillon (A)

Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. achaillon@health.ucsd.edu.

Ietza Bojorquez (I)

Departamento de Estudios de Población, El Colegio de la Frontera Norte. Tijuana, Mexico. ietzabch@colef.mx.

Jaime Sepúlveda (J)

Institute for Global Health Sciences, University of California. San Francisco, United States. Jaime.Sepulveda@ucsf.edu.

Alicia Yolanda Harvey-Vera (AY)

Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States/Facultad de Medicina, Universidad de Xochicalco. Tijuana, Mexico/United States-Mexico Border Health Commission. Tijuana, Mexico. alvera@health.ucsd.edu.

M Gudelia Rangel (MG)

Departamento de Estudios de Población, El Colegio de la Frontera Norte/United States-Mexico Border Health Commission. Tijuana, Mexico. grangel@colef.mx.

Britt Skaathun (B)

Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. bskaathun@health.ucsd.edu.

Sanjay R Mehta (SR)

Division of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States. srmehta@health.ucsd.edu.

Caroline Ignacio (C)

Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. cignacio@health.ucsd.edu.

Magali Porrachia (M)

Division of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States. mporrachia@health.ucsd.edu.

Davey M Smith (DM)

Division of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States. d13smith@health.ucsd.edu.

Steffanie A Strathdee (SA)

Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. sstrathdee@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH